Clinical Watch: December 2018

January 7, 2019

In this issue of Clinical Watch, we describe expanded uses of Hemlibra® and suggest criteria for the use of Dupixent® to treat severe asthma. We also review a study evaluating factors associated with non-adherence to essential chronic medications. Lastly, we review the prevalence of opioid polypharmacy in two Medicaid pharmacy programs.

For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Article
Electronic Visit Verification Helps States Comply with 21st Century Cures Act
Electronic Visit Verification Helps States Comply with 21st Century Cures Act

Next Article
CompTIA's HSITAG Celebrates 25 Years of Industry-Leading Work
CompTIA's HSITAG Celebrates 25 Years of Industry-Leading Work